Tagrisso (Osimertinib)

Tagrisso is used to treat non-small cell lung cancer (NSCLC) with specific genetic mutations, particularly the epidermal growth factor receptor (EGFR) T790M mutation. Developed by AstraZeneca, Tagrisso is classified as a tyrosine kinase inhibitor (TKI), which works by blocking the abnormal signaling pathways associated with EGFR mutations that drive cancer cell growth. Tagrisso has demonstrated impressive efficacy in extending progression-free survival and overall survival rates in patients with advanced NSCLC. Select your dosage below to view Tagrisso costs and place your order. Save up to 80% on Tagrisso price when you buy Tagrisso online from our online pharmacy.

*Product image is for reference only